In vitro‐in silico‐based analysis of the dose‐dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans

No abstract is available for this paper.

• Publication year

  2017

• Venue

  British Journal of Pharmacology

• Publication date

  2017-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bph.13900PMID 28585232PMCID PMC5523000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro‐in silico‐based analysis of the dose‐dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans

  2017cited by this paper
• Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison

  2016cited by this paper
• The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

  2015cited by this paper
• Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density

  2015influential reference
• Deconjugation of soy isoflavone glucuronides needed for estrogenic activity.

  2015cited by this paper
• Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors

  2015cited by this paper
• Prediction of in vivo developmental toxicity of all-trans-retinoic acid based on in vitro toxicity data and in silico physiologically based kinetic modeling

  2014cited by this paper
• Conversion of major soy isoflavone glucosides and aglycones in in vitro intestinal models.

  2014cited by this paper
• Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.

  2014influential reference
• Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.

  2014cited by this paper
• A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.

  2014cited by this paper
• Estrogen receptor-mediated effects of isoflavone supplementation were not observed in whole-genome gene expression profiles of peripheral blood mononuclear cells in postmenopausal, equol-producing women.

  2013influential reference
• Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.

  2013cited by this paper
• Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose–response curves for developmental toxicity of phenol in rat and human

  2013cited by this paper
• Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks.

  2013cited by this paper
• Absorption and plasma disposition of genistin differ from those of genistein in healthy women.

  2012influential reference
• Unusual Glucuronides

  2012cited by this paper
• Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse

  2012cited by this paper
• Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial

  2012influential reference
• Role of Metabolism in the Effects of Genistein and Its Phase II Conjugates on the Growth of Human Breast Cell Lines

  2012influential reference
• Substrate inhibition kinetics in drug metabolism reactions

  2011cited by this paper
• Metabolism and Disposition of Isoflavone Conjugated Metabolites in Humans after Ingestion of Kinako

  2011influential reference
• Molecular structure-affinity relationship of dietary flavonoids for bovine serum albumin

  2011influential reference
• Identification and quantification of daidzein-7-glucuronide-4′-sulfate, genistein-7-glucuronide-4′-sulfate and genistein-4′,7-diglucuronide as major metabolites in human plasma after administration of kinako

  2010influential reference
• Estrogenic properties of naturally occurring prenylated isoflavones in U2OS human osteosarcoma cells: Structure-activity relationships.

  2010influential reference
• Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density

  2010cited by this paper
• Genistein in the Presence of 17β-Estradiol Inhibits Proliferation of ERβ Breast Cancer Cells

  2009influential reference
• Effect of the β‐glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP‐glucuronosyltransferases

  2008cited by this paper
• Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.

  2008cited by this paper
• Plasma Profiling of Intact Isoflavone Metabolites by High-Performance Liquid Chromatography and Mass Spectrometric Identification of Flavone Glycosides Daidzin and Genistin in Human Plasma after Administration of Kinako

  2008influential reference
• Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.

  2007cited by this paper
• Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not.

  2007influential reference
• The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.

  2007influential reference
• Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies.

  2007cited by this paper
• Estrogenic activity of the chlorinated derivatives of estrogens and flavonoids using a GFP expression system.

  2007influential reference
• Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration.

  2006influential reference
• Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods.

  2006cited by this paper
• Biological differences among MCF-7 human breast cancer cell lines from different laboratories

  2005cited by this paper
• Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.

  2005influential reference
• The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor.

  2005cited by this paper
• Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine.

  2004cited by this paper
• A Pilot Clinical Study of Short-Term Isoflavone Supplements in Breast Cancer Patients

  2004influential reference
• Comparison of Caco-2, IEC-18 and HCEC cell lines as a model for intestinal absorption of genistein, daidzein and their glycosides.

  2004influential reference
• Interactions of Phytoestrogens with Estrogen Receptors α and β (III). Estrogenic Activities of Soy Isoflavone Aglycones and Their Metabolites Isolated from Human Urine

  2004influential reference
• Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

  2004cited by this paper
• Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.

  2004influential reference
• Soy, isoflavones, and breast cancer risk in Japan.

  2003cited by this paper
• In vitro-in vivo extrapolation: estimation of human serum concentrations of chemicals equivalent to cytotoxic concentrations in vitro.

  2003cited by this paper
• Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro.

  2002influential reference
• Relationship between Estrogen Receptor-Binding and Estrogenic Activities of Environmental Estrogens and Suppression by Flavonoids

  2002influential reference
• Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases.

  2002cited by this paper
• Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.

  2001influential reference
• Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.

  2001influential reference
• Estrogen Receptor Mediates the Proliferative but Not the Cytotoxic Dose-Dependent Effects of Two Major Phytoestrogens on Human Breast Cancer Cells

  2001influential reference
• Interaction of Phytoestrogens with Estrogen Receptors α and β

  2001cited by this paper
• Interaction of phytoestrogens with estrogen receptors alpha and beta.

  2001influential reference
• Sensitivity analysis of a physiological model for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): assessing the impact of specific model parameters on sequestration in liver and fat in the rat.

  2000cited by this paper
• Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast.

  1999cited by this paper
• Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

  1998influential reference
• Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β.

  1998influential reference
• Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo.

  1998influential reference
• Physiological Parameter Values for Physiologically Based Pharmacokinetic Models

  1997cited by this paper
• A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans

  1997cited by this paper
• Molecular effects of genistein on estrogen receptor mediated pathways.

  1996influential reference
• Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.

  1996influential reference
• Dietary Estrogens Act through Estrogen Receptor-Mediated Processes and Show No Antiestrogenicity in Cultured Breast Cancer Cells.

  1994influential reference
• Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans.

  1987cited by this paper

• Intracellular Pharmacokinetics of Antidiabetic Drugs: A Focused Narrative Review of Subcellular Distribution (2015-2025).

  2026cites this paper
• A Parent–Metabolite Middle-Out PBPK Model for Genistein and Its Glucuronide Metabolite in Rats: Integrating Liver and Enteric Metabolism with Hepatobiliary and Enteroluminal Transport to Assess Glucuronide Recycling

  2025cites this paper
• The potential of natural deep eutectic solvent in polyphenol extraction of Timonius flavescens (Jacq) Baker as an anti-breast cancer agent and its toxicity evaluation

  2025cites this paper
• A novel method to derive a human safety limit for PFOA by gene expression profiling and modelling

  2024cites this paper
• Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.

  2023cites this paper
• Virtual Screening of Natural Compounds Against Six Protein Receptors Coded by The SARS-CoV-2 Genome

  2023cites this paper
• Derivation of a Human In Vivo Benchmark Dose for Bisphenol A from ToxCast In Vitro Concentration Response Data Using a Computational Workflow for Probabilistic Quantitative In Vitro to In Vivo Extrapolation

  2022cites this paper
• Predictive Performance of Next Generation Human Physiologically Based Kinetic (PBK) Models Based on In Vitro and In Silico Input Data

  2022cites this paper
• Predictive performance of next generation human physiologically based kinetic (PBK) model predictions based on in vitro and in silico input data_suppl1

  2022cites this paper
• Experimental and Molecular Docking Studies of Estrogen-like and Anti-osteoporosis Activity of compounds in Fructus Psoraleae.

  2021cites this paper
• Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits

  2021cites this paper
• Genistein: Dual Role in Women’s Health

  2021cites this paper
• Comparing nutritional and digestibility aspects of sustainable proteins using the INFOGEST digestion protocol

  2021cites this paper
• Use of Physiologically Based Kinetic Modeling to Predict Rat Gut Microbial Metabolism of the Isoflavone Daidzein to S‐Equol and Its Consequences for ERα Activation

  2020cites this paper
• Preparation and Characterization of PEG-PLA Genistein Micelles Using a Modified Emulsion-Evaporation Method

  2020cites this paper
• Metabolic tracking of isoflavones in soybean products and biosamples from healthy adults after fermented soybean consumption.

  2020cites this paper
• Potential of ToxCast Data in the Safety Assessment of Food Chemicals

  2020cites this paper
• Selecting the dose metric in reverse dosimetry based QIVIVE

  2019cites this paper
• Combining In Vitro Data and Physiologically Based Kinetic Modeling Facilitates Reverse Dosimetry to Define In Vivo Dose–Response Curves for Bixin‐ and Crocetin‐Induced Activation of PPARγ in Humans

  2019cites this paper
• The role of polycyclic aromatic hydrocarbons in developmental toxicity of petroleum substances

  2019cites this paper
• Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazone.

  2019cites this paper
• A Computational Workflow for Probabilistic Quantitative in Vitro to in Vivo Extrapolation

  2018cites this paper
• The use of plants containing genotoxic carcinogens as foods and medicine.

  2018cites this paper
• In vitro‐in silico‐based analysis of the dose‐dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans

  2017cites this paper
• In vitro bioassays to evaluate beneficial and adverse health effects of botanicals: promises and pitfalls.

  2017cites this paper